Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 20, 2021 07:05 ET | Source: Senti Bio

Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies

- Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross proceeds, over $153 million of which is fully committed in a common...
August 17, 2021 08:00 ET | Source: Senti Bio

Senti Bio Adds Prominent Scientific and Industry Leaders to its Scientific Advisory Board

- Members include world-leading experts in fields of immunotherapy drug discovery and development and commercial oncology therapeutics - - Dr. James Collins, a founder of the field of synthetic...